Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Resistant Cancer”

3,575 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 3,575 results

Not applicableEnrolling By InvitationNCT07035067
What this trial is testing

Multidimensional Burden of Platinum Resistant Ovarian Cancer (PROC) on Patients and Caregivers in Canada

Who this might be right for
Ovarian CancerCaregiver BurdenPatient Burden
PeriPharm 150
Large-scale testing (Phase 3)Looking for participantsNCT06276465
What this trial is testing

Treatment With Darolutamide +/- Radiation Therapy for Patients With a Castration Resistant Cancer and Metastases Detected by Functional Imaging

Who this might be right for
Prostatic Cancer, Castration-Resistant
UNICANCER 336
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07022301
What this trial is testing

Sintilimab Plus Anlotinib as Second or Further-line Therapy for ES-SCLC Who Have Progressed After Anti-PD-1/L1 Therapy

Who this might be right for
Small Cell Lung Cancer Extensive StageResistance to Immunotherapy
First Affiliated Hospital of Wannan Medical College 25
Not applicableLooking for participantsNCT05435495
What this trial is testing

Mechanisms of Resistance to PSMA Radioligand Therapy

Who this might be right for
Prostate Cancer
University of California, San Francisco 125
Testing effectiveness (Phase 2)Study completedNCT00453895
What this trial is testing

Sunitinib in Refractory Adrenocortical Carcinoma

Who this might be right for
Adrenocortical Carcinoma
University of Wuerzburg 39
Not applicableUnknownNCT04567875
What this trial is testing

Evaluation of Cardiotoxicity and Hypertension in Patients With Non Metastatic Castration Resistant Prostatic Carcinoma

Who this might be right for
Castration-resistant Prostate Cancer
Ospedale Andrea Tortora di Pagani 54
Testing effectiveness (Phase 2)Ended earlyNCT01109615
What this trial is testing

Pemetrexed and Gemcitabine for Treatment Resistant Patients With Metastatic Colorectal Cancer and KRAS Mutations

Who this might be right for
Metastatic Colorectal Cancer
Vejle Hospital 40
Not applicableEnded earlyNCT01775176
What this trial is testing

Effect of Weight & Insulin Sensitivity on Reproductive Function in PCOS: Studies in Skeletal Muscle & Adipose

Who this might be right for
Polycystic Ovary Syndrome
Pennington Biomedical Research Center 17
Testing effectiveness (Phase 2)Looking for participantsNCT06249750
What this trial is testing

Clinical Application of Near-infrared Whole Body Heat Shock Multimodal Technique in Treatment of Castration-resistant Prostate Cancer

Who this might be right for
Metastatic Castration-resistant Prostate Cancer (CRPC)
Pengyuan Liu 60
Early research (Phase 1)Study completedNCT06517433
What this trial is testing

First-in-Human Dose Escalation Study of XMT-1536 in Cancers Likely to Express NaPi2b

Who this might be right for
Platinum Resistant Ovarian CancerNon Small Cell Lung Cancer Metastatic
Mersana Therapeutics 62
Testing effectiveness (Phase 2)Looking for participantsNCT06361940
What this trial is testing

Molecular Analyses to Predict Pathways of Endocrine Resistance Following Short Term Neoadjuvant Endocrine Treatment in Patients With Hormone Receptor-Positive HER2-negative Breast Cancer

Who this might be right for
Breast Cancer
Medical College of Wisconsin 100
Not applicableStudy completedNCT05062135
What this trial is testing

Progesterone Action on Endometrium of PCOS

Who this might be right for
Polycystic OvaryProgesterone Resistance
University of Sao Paulo General Hospital 36
Early research (Phase 1)Study completedNCT00551850
What this trial is testing

A Safety Study of an Oral EGFR Inhibitor, AV-412, Administered Three Times Weekly in Advanced Solid Tumor Patients

Who this might be right for
Advanced CancerRefractory Cancer
AVEO Pharmaceuticals, Inc. 37
Not applicableStudy completedNCT01833208
What this trial is testing

Radiation Therapy in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Receiving Sipuleucel-T

Who this might be right for
Hormone-Resistant Prostate CancerMetastatic Malignant Neoplasm in the BoneRecurrent Prostate Carcinoma+1 more
Roswell Park Cancer Institute 15
Not applicableUnknownNCT02267590
What this trial is testing

Tissue Collection for Biomarkers Determining Resistance to Ibrutinib

Who this might be right for
Mantle Cell LymphomaChronic Lymphocytic Leukaemia
Royal Marsden NHS Foundation Trust 120
Early research (Phase 1)Looking for participantsNCT05691504
What this trial is testing

Testing the Combination of APG-1252 (Pelcitoclax) and Cobimetinib in Recurrent Ovarian and Endometrial Cancers

Who this might be right for
Advanced Endometrial CarcinomaMetastatic Endometrial CarcinomaMetastatic Fallopian Tube Carcinoma+8 more
National Cancer Institute (NCI) 42
Early research (Phase 1)Study completedNCT03811652
What this trial is testing

A Multiple Ascending Dose Study of MEDI7247 in Advanced or Metastatic Solid Tumors

Who this might be right for
Non Small Cell Lung Cancer Squamous (NSCLC-Sq)Head and Neck Squamous Cell Carcinoma (HNSCC)Small Cell Lung Cancer (SCLC)+3 more
MedImmune LLC 8
Early research (Phase 1)Study completedNCT00441155
What this trial is testing

Patients Completing Core Protocol (CAMN107A2103), Exhibiting Stable Disease (SD), Partial Response (PR) or Complete Response (CR) to Nilotinib in Combination With Imatinib

Who this might be right for
Gastrointestinal Stromal Tumors
Novartis Pharmaceuticals 14
Early research (Phase 1)UnknownNCT03468751
What this trial is testing

Phase 1 Study of HLX10, a Monoclonal Antibody Targeting Programmed Death-1 (PD-1) in Patients With Advanced Solid Tumors

Who this might be right for
Solid Tumor
Henlix, Inc 30
Testing effectiveness (Phase 2)WithdrawnNCT00811031
What this trial is testing

Preoperative Docetaxel for Localized Progressive Castration-resistant Prostate Cancer (CRPC)

Who this might be right for
Prostate Cancer
M.D. Anderson Cancer Center
Load More Results